Because SST can be elevated in diabetes (19), inhibition of insulin secretion can occur via SST acting both on SSTR5 (the dominant β-cell receptor subtype) but also SSTR2, which is present but with 10-fold lower binding capacity for SST28 (53). Here, INS is linked to diabetes mellitus.